iVascular has announced that its Angiolite drug-eluting stent (DES) offers a 6mm overexpansion capacity, which the company describes as one of the highest overexpansion capacities for medium and large vessels.
Angiolite is a sirolimus-eluting coronary stent, indicated for patients with symptomatic ischaemic heart disease due to de novo stenotic and restenotic lesions and patients with occlusive disease due to acute myocardial infarction.
The device is composed of alternating links to achieve a homogeneous arterial coverage with high rates of endothelialisation due to its fluorinated polymer and TransferWise, proprietary iVascular nanotechnology.
Angiolite’s overexpansion capacity is 6mm for diameters of 4mm and 4.5mm, iVascular said in a press release, and for small vessels, from 2mm to 2.5mm, the maximum overexpansion capacity is 4mm. For medium vessels, such as 2.75mm, 3mm and 3.5mm, Angiolite offers 5.25mm as a maximum post-dilatation diameter.
In its press release, the company said that the objective of this new feature is to “bring value to the clinical daily practice in order to enhance the outcomes of complex procedures, as left main and long bifurcated segments”.